UroGen Pharma (URGN)

UroGen Pharma (URGN) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• URGN last traded at $34.35, 4.98% on the day.
• UroGen Pharma: market cap $1.60B, P/E -17.4, revenue $188.73M over the last four quarters, next earnings 2026-11-04.
• Over the past year URGN returned 73.05%; year to date 46.67%.

Updated 2026-11-02 23:10 UTC